EX-8.1 10 ex8_1.htm EXHIBIT 8.1 ex8_1.htm
Exhibit 8.1

Subsidiaries
Country of Incorporation
Voting Interest
Subsidiaries of Midatech Pharma PLC
    
Midatech Pharma (Wales) Limited
England and Wales
100%
Midatech Limited
England and Wales
100%
Midatech Pharma US Inc.
United States (Delaware)
100%
Midatech Pharma Pty Limited
Australia
100%
Joint Ventures with Midatech Limited
    
MidaSol Therapeutics GP (1)
Cayman Islands
50%
Syntara LLC (2)(3)
United States (Delaware)
50%
Subsidiaries of Midatech Limited
    
Midatech Pharma Espana SL
Spain
100%
Midatech Andalucia SL (3)
Spain
100%
Pharmida AG (3)
Switzerland
100%
Subsidiaries of Midatech Pharma US Inc.
    
DARA Therapeutics, Inc.
United States (North Carolina)
100%

                                 
(1) 
Joint venture between Midatech Limited and MonoSol.
(2) 
Joint venture between Midatech Limited and Immunotope Inc. The percentage ownership of the entity isdetermined by reference to the partnership agreement and varies from time to time depending on capitalcommitted. While 50% is the economic interest, Midatech Limited can currently direct 49% of the voting rights.
(3) 
Dormant entity or entities in the process of being wound-down.